Gabather (abbreviated form of GABA Therapeutics) focuses on the development of highly potent and selective GABAA receptor modulators targeting the principal inhibitory neurotransmitter in the mammalian brain, gamma aminobutyric acid (GABA). Our drug development candidates are small molecular weight compounds designed through proprietary pharmacophore modelling. Our development pipeline includes candidates targeting the GABAA receptor in both preclinical and clinical development and we aim to produce novel pharmaceuticals such as antipsychotics, antidepressants, anxiolytics, analgesics and cognitive enhancers to treat CNS diseases with high unmet need.
| Website | http://www.gabather.com/ |
| Employees | 4 (0 on RocketReach) |
| Founded | 2014 |
| Address | Forskargatan 20 J, Södertälje, Stockholm County 151 36, SE |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Drug Development, Pharmaceutical Research, Receptor Pharmacology, New Drug Discovery, Central Nervous System, Therapeutic Agents, Biotechnology, Brain Function, Neurological Disorders, Clinical Trials |
Looking for a particular Gabather employee's phone or email?
Gabather Questions
Gabather is based in Södertälje, Stockholm County.
Related Companies
